[Announcement] HGPI Endorsed “Urgent Joint Statement on the Treatment of Comprehensive Genomic Profiling Test in the Revision of Medical Service Fee in FY2024” (June 19, 2024)
date : 6/19/2024
Tags: NCDs, Precision Cancer Medicine
On June 19, 2024, Health and Global Policy Institute (HGPI) endorsed the “Urgent Joint Statement on the Treatment of Comprehensive Genomic Profiling Tests in the Revision of Medical Service Fee in FY2024.”
In addition to our Organization, this Joint Statement is endorsed by the Japan Federation of Cancer Patient Groups, the European Federation of Pharmaceutical Industries and Associations (EFPIA Japan), the Japanese Society of Medical Oncology, and the Japanese Society of Clinical Oncology.
In “Joint Statement on the Implementation of Comprehensive Genomic Profiling test” of December 15, 2023, we requested that “Expand insurance coverage for cancer gene panel testing so that it can be done at the appropriate time from the time of initial treatment.” However, since this request was not approved in the 2024 revision of medical service fees, the organizations concerned have decided to once again jointly prepare this statement in order to provide appropriate medical care to patients. This joint statement will be submitted to the Minister of Health, Labour and Welfare, Mr. Keizo Takemi, and other relevant officials.
Currently, the cancer gene panel tests (cancer comprehensive genomic profiling tests) approved for use under the Japanese health insurance system is only for “solid tumors for which no standard treatment is available, or with local progression or metastasis for which standard treatment has been terminated (including those for whom termination is expected)”.
Under these circumstances, we are concerned that patients will miss the opportunity to select the optimal therapeutic agent. We are also concerned that even if a comprehensive genomic profiling test is performed after the completion of standard treatment and a gene mutation that can be treated with drug therapy is found, the patient will continue to miss the opportunity for treatment due to the deterioration of his/her general condition, resulting in an unfortunate situation where it is too late.
Please note that the joint statement documents are only available in Japanese.
Top Research & Recommendations Posts
- [Survey Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Preliminary Version) (September 11, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Policy Recommendations] Three Necessary Perspectives for Formulating the Basic Plan for the Promotion of Policies on Dementia: Creating a Society That is Inclusive for All People at All Times (April 1, 2024)
- [Policy Recommendations] Dementia Policy for an Inclusive Society 2024: HGPI Recommendations on The Basic Plan on Dementia to Promote an Inclusive Society (Draft) and Basic Measures (Draft) (August 13, 2024)
Featured Posts
-
2024-07-03
[Japanese Version Release] “Call for Actionable Steps in Response to the Rising Threat of Antimicrobial Resistance (AMR)” (July 3, 2024)
-
2024-09-26
[Event Report] UN General Assembly High-Level Meeting on AMR Side Event “Global Action on AMR: Advancing Healthy Longevity and Sustainability under UHC” (September 25, 2024, New York City, USA)
-
2024-09-26
[Registration Open] HGPI Salon Special Edition “The 2024 U.S. Presidential Election’s Impact on Japan’s Healthcare Policies: Future Implications for U.S.-China Relations and U.S.-Japan Cooperation” (October 28, 2024)
-
2024-09-27
[HGPI Policy Column] (No. 48) From the Meaningful Involvement Promotion Project: The Resolution on Social Participation at the 77th World Health Assembly
-
2024-10-01
[Event Report] Online Information Session for Japan’s Patient Expert Platform (J-PEP), a Members Only Website (September 6, 2024)